摘要
目的研究依达拉奉、奥扎格雷钠联合治疗2型糖尿病并发急性脑梗死的效果。方法根据随机数字表方法对2016年2月—2017年2月60例2型糖尿病并发急性脑梗死患者分组。对照组采用奥扎格雷钠治疗,联合治疗组采用依达拉奉、奥扎格雷钠联合治疗。对两组患者治疗前后ESS评分、BI指数和2型糖尿病并发急性脑梗死干预效果、用药不良反应发生率进行比较。结果联合治疗组2型糖尿病并发急性脑梗死干预效果明显高于对照组,P<0.05。两组不良反应差异无统计学意义,P>0.05。治疗前ESS评分、BI指数差异无统计学意义,P>0.05。联合治疗组患者治疗后ESS评分、BI指数均明显高于对照组,P<0.05。结论依达拉奉、奥扎格雷钠联合治疗2型糖尿病并发急性脑梗死的效果确切,可改善患者预后和神经功能,改善其日常生活能力,药物无严重副作用。
Objective To study the effect of edaravone and ozagrel sodium in the treatment of type 2 diabetes complicated with acute cerebral inthrction. Methods 60 patients with type 2 diabetes mellitus complicated with acute cerebral infarction were divided into two groups according to the random number table method form February 2016 to February 2017. The control group was treated with ozagrel sodium and the combination therapy group was treated with edaravone and ozagrel sodium. The ESS score, BI index and type 2 diabetes mellitus complicated with acute cerebral infarction were compared between the two groups before and after treatment, and the incidence of adverse reactions was compared. Results The intervention effect of type 2 diabetes mellitus complicated with acute cerebral infarction was significantly higher than that of the control group （P 〈 0.05）. There were no significant differences in adverse reactions between the two groups （P 〉 0.05）. Before treatment, there were no significant difference ~br ESS score, BI index（ P 〉 0.05）. The ESS score and BI index of the patients in the combination therapy group were significantly higher than those in the control group （P 〈 0.05）. Conclusion The combination of edaravone and ozagrel sodium in the treatment of type 2 diabetes complicated with acute cerebral infarction can improve the prognosis and neurological function, improve the ability of daily life and no serious side effects.
出处
《中国卫生标准管理》
2017年第27期86-87,共2页
China Health Standard Management
关键词
依达拉奉
奥扎格雷钠
2型糖尿病并发急性脑梗死
效果
edaravone
ozagrel sodium
type 2 diabetes complicated with acute cerebral infarction
effect
